Oyster Point Pharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 12, 2022 at 01:36 am IST
Oyster Point Pharma, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was USD 4.69 million. Net loss was USD 49.94 million compared to USD 22.02 million a year ago. Basic loss per share from continuing operations was USD 1.87 compared to USD 0.85 a year ago.
For the six months, revenue was USD 7.4 million. Net loss was USD 97.83 million compared to USD 40.93 million a year ago. Basic loss per share from continuing operations was USD 3.67 compared to USD 1.58 a year ago.